MARC 닫기

• LDR

  00000cam c2200205 c 4500

• 001

  000000588007

• 005

  20201230143910

• 006

  m d

• 007

  cr |n|---|||||

• 008

  170930s2017 xx obf 001a0 engd

• 019

  ▼a  1005690252

• 020

  ▼a  1284151875

• 020

  ▼a  9781284151879
  ▼q  (electronic bk.)

• 020

  ▼z  9781284124705

• 020

  ▼z  1284124703

• 035

  ▼a  2127200
  ▼b  (N$T)

• 035

  ▼a  (OCoLC)1004984915
  ▼z  (OCoLC)1005690252

• 040

  ▼a  EBLCP
  ▼b  eng
  ▼c  EBLCP
  ▼d  OCLCO
  ▼d  YDX
  ▼d  OCLCO
  ▼d  OCLCQ
  ▼d  OCLCA
  ▼d  N$T
  ▼d  248023
  ▼e  pn

• 049

  ▼a  MAIN

• 050

  ▼a  RC606.6
  ▼b  .S29 2017

• 060

  ▼a  WC 39
  ▼b  H67377 2017

• 082

  ▼a  616.9792

• 100

  ▼a  Sax, Paul E.

• 245

  ▼a  HIV Essentials 2017
  ▼h  [electronic resource].

• 250

  ▼a  8th ed.

• 260

  ▼a  Sudbury:
  ▼b  Jones & Bartlett Learning,
  ▼c  2017.

• 300

  ▼a  1 online resource (652 pages).

• 336

  ▼a  text
  ▼b  txt
  ▼2  rdacontent

• 337

  ▼a  computer
  ▼b  c
  ▼2  rdamedia

• 338

  ▼a  online resource
  ▼b  cr
  ▼2  rdacarrier

• 500

  ▼a  Cardiac Complications.

• 504

  ▼a  Includes bibliographical references and index.

• 505

  ▼a  Cover Page; Title Page; Copyright Page; Editorial Note; Tables and Figures; Table of Contents; Contributors; Acknowledgements; Notice; Abbreviations for Antiretroviral Agents; Other Abbreviations; 1. Overview of HIV Infection; Overview; Stages of HIV Infection; Acute HIV Infection; Differential Diagnosis; Signs and Symptoms; Laboratory Findings; Diagnostic Testing; Management; 2. Testing for HIV and Baseline Evaluation; HIV Diagnostic Testing; Whom to Test; Testing for HIV; HIV Antibody Tests; Selected Licensed HIV Diagnostic Tests; HIV Viral Load Assays; Uses; Assays and Interpretation.

• 505

  ▼a  IndicationsInitial Assessment of HIV-Infected Patients; Clinical Evaluation; Laboratory Testing; CD4 Cell Count; 3. Treatment of HIV Infection; Initiation of Antiretroviral Therapy; Selection of an Optimal Initial Antiretroviral Regimen; Antiretroviral Therapy Adverse Effects; 4. Management OF the Treatment-Experienced Patient; Antiretroviral Treatment Failure; Virologic Response Definitions; Evaluation of Virologic Failure; Important Genotypic Resistance Patterns; Poor CD4 Recovery Despite Virologic Suppression; Regimen Switching in the Setting of Virologic Suppression (See Table 4-2).

• 505

  ▼a  General Principles of Regimen SwitchingRegimen Switch Strategies in the Setting of Drug Toxicity; 5. Prophylaxis and Treatment of Opportunistic Infections; Prophylaxis of Opportunistic Infections; Treatment of Opportunistic Infections; Aspergillosis, Invasive; Bacterial respiratory Diseases; Bartonella Infections; Campylobacteriosis; Candidiasis (Mucosal); Chagas Disease; Clostridium Difficile Diarrhea/Colitis; Coccidioidomycosis; Cryptococcal Meningitis; Cryptosporidiosis; Cytomegalovirus Disease; Hepatitis B Virus; Hepatitis C Virus; Herpes Simplex Virus Disease; HHV-8 Infection.

• 505

  ▼a  Histoplasma CapsulatumHuman Papillomavirus Disease; Isospora Belli Infection; Leishmaniasis, Cutaneous; Malaria; Microsporidiosis; Mycobaterium Avium Complex Disease; Mycobaterium Tuberculosis; Penicilliosis; Pneumocystis Pneumonia; Progressive Multifocal Leukoencephalopathy; Salmonellosis; Shigellosis; Toxoplasma Gondii Encephalitis; Treponema Pallidum (Syphilis); Varicella-Zoster Virus Disease; 6. Complications of HIV Infection; Hematologic Complications; Thrombocytopenia/anemia; Neutropenia; Eosinophilia; Oncologic Complications; Kaposi's Sarcoma; Non-Hodgkin's Lymphoma.

• 505

  ▼a  Primary CNS LymphomaCervical/Anal Cancer; Endocrine Complications; Adrenal Insufficiency; Hypogonadism; Thyroid Disease; Pancreatitis; Hyperglycemia; Hypoglycemia; Ovarian Complications; Bone Disease; Morphologic Complications of Therapy; Lipoatrophy; Fat Accumulation and Weight Gain; Prevention of Lipodystrophy; Lipid Abnormalities; Gastrointestinal Tract Complications; Anorexia; Nausea/vomiting; Diarrhea; Oral/esophageal ulcers; HIV cholangiopathy; Renal Complications; HIV-Associated; Medication-Related; HCV-Associated; Heroin Nephropathy; Inhibition of Tubular Secretion of Creatinine.

• 520

  ▼a  Everything needed to manage HIV patients in the office, on the ward, and in the ICU. Incorporates clinical guidelines into a step-by-step guide to the diagnosis, evaluation, management, and prevention of HIV infection and its complications. Topics include: opportunistic infections and other HIV complications, treatment of HIV and pregnancy, antiretroviral drug summaries, post-exposure prophylaxis, as well as commercially available dosage forms for all ARVs.

• 588

  ▼a  Print version record.

• 650

  ▼a  HIV (Viruses)

• 650

  ▼a  HIV (Viruses)
  ▼v  Handbooks, manuals, etc.

• 650

  ▼a  HIV infections
  ▼v  Handbooks, manuals, etc.

• 650

  ▼a  Antiretroviral agents
  ▼v  Handbooks, manuals, etc.

• 650

  ▼a  HIV Infections.

• 650

  ▼a  HIV Infections
  ▼x  drug therapy.

• 650

  ▼a  Anti-HIV Agents
  ▼x  therapeutic use.

• 650

  ▼a  Antiretroviral Therapy, Highly Active.

• 700

  ▼a  Cohen, Calvin J.

• 700

  ▼a  Kuritzkes, Daniel R.

• 776

  ▼i  Print version:
  ▼a  Sax, Paul E.
  ▼t  HIV Essentials 2017.
  ▼d  Sudbury : Jones & Bartlett Learning, ©2017,
  ▼z  9781284124705

• 856

  ▼3  EBSCOhost
  ▼u  http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=2127200

• 990

  ▼a  강리원

• 991

  ▼a  eBook